Allergy Diagnostics And Therapeutics Market Size Projected to Reach $85.94 billion by 2034 | 9.83%

According to Straits Research, the global allergy diagnostics and therapeutics market size was valued at $37.03 billion in 2025 and is projected to grow from $40.60 billion in 2026 to $85.94 billion by 2034, registering a CAGR of 9.83% during the forecast period 2026–2034.

Market Dynamics

Growth in the allergy diagnostics and therapeutics market is primarily driven by rising clinical adoption of structured allergy evaluation pathways that encourage early testing for food, inhaled, and drug-related allergies across both hospital and outpatient settings. However, the market faces a restraint as multi-step diagnostic procedures, including repeated in vivo confirmations and extended follow-up visits, lead to lower completion rates among patients who may discontinue evaluation before receiving final treatment recommendations. Despite this challenge, the market presents a clear opportunity through the expansion of mobile allergy testing units and community-based outreach programs in emerging economies, which bring diagnostic services closer to underserved districts and create new entry points for therapeutic adoption across previously unreached populations.

Market Segments

1. By Type (2026-2034)
   1. Diagnostics
      1. Instruments
      2. Consumables
      3. Services
   2. Therapeutics
      1. Antihistamines
      2. Decongestants
      3. Corticosteroids
      4. Mast Cell Stabilizers
      5. Leukotriene Inhibitors
      6. Nasal Anti-cholinergic
      7. Immuno-modulators
      8. Epinephrine
      9. Immunotherapy